Futura Medical plc

As of June 30, 2026, Futura Medical plc carries a market capitalization of 302.29M, placing it among publicly traded companies globally. Its enterprise value stands at 177.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Futura Medical plc's next confirmed earnings release is scheduled for April 14, 2027.

As of June 30, 2026, Futura Medical plc has 581.33M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Futura Medical plc maintains a current ratio of 1.61, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Futura Medical plc's stock has declined approximately 93.96% over the past 52 weeks. The 50-day moving average sits at 0.27, while the 200-day moving average is 0.74.

These figures are as of June 30, 2026. Total book value stands at 200.52M, with working capital of 131.28M providing operational flexibility.

Futura Medical plc's most recent stock split took place on October 22, 2018 with a 699:703 split ratio.